(Q37606087)

21 August 2017

A-ring modified betulinic acid derivatives as potent cancer preventive agents (English)

1 reference

21 August 2017

3

Harukuni Tokuda

1 reference

21 August 2017

2

Kyoko Nakagawa-Goto

1 reference

21 August 2017

8

Kuo-Hsiung Lee

1 reference

21 August 2017

Hsin-Yi Hung

1

1 reference

21 August 2017

Akira Iida

4

1 reference

21 August 2017

Nobutaka Suzuki

5

1 reference

21 August 2017

Ibrahim D Bori

6

1 reference

21 August 2017

Keduo Qian

7

1 reference

21 August 2017

language of work or name

English

0 references

publication date

16 December 2013

1 reference

Bioorganic & Medicinal Chemistry Letters

21 August 2017

4

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

21 August 2017

24

1 reference

21 August 2017

3

1 reference

21 August 2017

1005-1008

1 reference

Anti-AIDS agents 81. Design, synthesis, and structure-activity relationship study of betulinic acid and moronic acid derivatives as potent HIV maturation inhibitors

21 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3936349

Cancer preventive agents 9. Betulinic acid derivatives as potent cancer chemopreventive agents

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3936349

Anti-AIDS agents. 78. Design, synthesis, metabolic stability assessment, and antiviral evaluation of novel betulinic acid derivatives as potent anti-human immunodeficiency virus (HIV) agents

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3936349

Citrus limonoids: analysis, bioactivity, and biomedical prospects

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3936349

The discovery of a class of novel HIV-1 maturation inhibitors and their potential in the therapy of HIV.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3936349

Ursolic acid derivatives induce cell cycle arrest and apoptosis in NTUB1 cells associated with reactive oxygen species.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3936349

A short-term in vitro assay for promoter substances using human lymphoblastoid cells latently infected with Epstein-Barr virus

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3936349

Chemoprevention: First line of defence.

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3936349

Synthesis and anti-HIV activity of bi-functional betulinic acid derivatives

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3936349

Cancer chemopreventive activity of phenylpropanoids and phytoquinoids from Illicium plants

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3936349

Cancer chemopreventive activity of flavanones on Epstein-Barr virus activation and two-stage mouse skin carcinogenesis

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3936349

Inhibitory effects of cucurbitane triterpenoids on Epstein-Barr virus activation and two-stage carcinogenesis of skin tumors

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3936349

Triterpene Acids fromPoria cocosand Their Anti-Tumor-Promoting Effects

1 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24411124

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.BMCL.2013.12.041

1 reference

21 August 2017

1 reference

21 August 2017

PubMed publication ID

24411124

1 reference